We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

DSM Biologics and Crucell Announce Licensing Agreement with Medarex

This license agreement allows Medarex to use the PER.C6® production platform in its antibody research.
News

Millipore Corporation and Novozymes Form Strategic Alliance to Supply Animal-Free Cell Culture Supplements for Bioprocessing

Alliance will accelerate launch of new animal-free supplements and provide customers with a source of high performance cell culture products.
News

BD Acquires Right to Negotiate Business Relationship for Accelr8’s BACcel® Technology

Becton Dickinson has purchased an exclusive right to negotiate for a business relationship to develop Accelr8’s BACcel® rapid diagnostic platform.
News

Cancer Cell Line Developed that is Resistant to new Cancer Therapy

Researchers found the HDAC inhibitor-resistant cell line resistant to many therapies but highly sensitive to heat shock protein 90 inhibitors, another emerging cancer treatment.
News

ImmunoVaccine Technologies to Acquire Immunotope

The acquisition will bring together IVT's signature VacciMax® platform with Immunotope's portfolio of immunotherapeutic antigens and antigen discovery platform.
News

The Closest Look Ever at Native Human Tissue

EMBL researchers have published the first 3D image of human skin at molecular resolution and reveal the molecular Velcro-like organization that interlinks cells.
News

Beckman Coulter Collaborates in Multisite Research Project for Cardiovascular Disease Markers

The collaborative research will seek to discover genetic signatures for cardiovascular disease and obesity-related hypertension.
News

BioSeek Initiates Systems Biology Compound Evaluation Collaboration with UCB

BioSeek will apply its BioMAP® systems to evaluate a number of UCB compounds across several target classes.
News

AVEO Pharmaceuticals and Lilly Sign Collaboration for Clinical Drug Response Project

Agreement highlights growing interest in novel biology platform that identifies clinical response of cancer drugs.
News

Buck Institute and Neurobiological Technologies Partner to Develop Treatment for Huntington's Disease

The research involves fibroblast growth factor-2 (FGF-2), a naturally occurring protein that has been studied extensively for its neuroprotective properties.
Advertisement